Información del producto
DBPR112 is an analog that belongs to the group of kinase inhibitors. It has been shown to inhibit various kinases, which are enzymes involved in cellular signaling pathways that regulate cell growth and division. DBPR112 has demonstrated anticancer activity in vitro against a range of cancer cells, including Chinese hamster ovary cells, human breast cancer cells, and tumor xenografts. It also induces apoptosis, or programmed cell death, in cancer cells. DBPR112 is excreted in urine and may be used as a potential biomarker for monitoring anticancer therapy. This drug is not related to oseltamivir or any other antiviral medication but rather acts on protein targets within the cancer cell.
Propiedades químicas
Consulta técnica sobre: 3D-BZB54949 DBPR112
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.